Frequency of Mycobacterium Tuberculosis infection among Iranian patients with HIV/AIDS by PPD test

Acta Medica Iranica

Volumn 48, Issue 1, 2010, Pages 67-71

  Jam, Sara ^a   Sabzvari, Duman ^a   SeyedAlinaghi, SeyedAhmad ^a   Fattahi, Fatemeh ^a   Jabbari, Hossain ^a   Mohraz, Minoo ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acquired immunodeficiency syndrome; HIV; Tuberculin; Tuberculosis

Indexed keywords

TUBERCULIN; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AIDS PATIENT; ANAMNESIS; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; FEMALE; HEMOPHILIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION PREVENTION; IRAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTION; PHYSICAL EXAMINATION; PRESCHOOL CHILD; SCHOOL CHILD; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; IRAN; MALE; MIDDLE AGED; TUBERCULIN; TUBERCULIN TEST; TUBERCULOSIS;

EID: 77649203485     PISSN: 00446025     EISSN: 00446025     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Small PM. Tuberculosis research. Balancing the portfolio. JAMA 1996;276(18):1512-3.
2. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999;282(7):677-86.
3. Raviglione MC, Snider DE Jr, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995;273(3):220-6.
4. Cantwell MF, Binkin NJ. Tuberculosis in sub-Saharan Africa: a regional assessment of the impact of the human immunodeficiency virus and National Tuberculosis Control Program quality. Tuber Lung Dis 1996;77(3):220-5.
5. th ed. Ottawa: Health Canada and the Canadian Lung Association; 2000. p. 45-65.
6. Narain JP, Raviglione MC, Kochi A. HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tuber Lung Dis 1992;73(6):311-21.
7. Canete-Mujeres M, Montoya JC, Santiago E, Manalo M. Prevalence of tuberculosis infection among household contacts of HIV patients with culture-confirmed pulmonary tuberculosis. Phil J Microbiol Infect Dis 2004;33:1-5.
8. AIDS Control and Prevention (AIDSCAP). Project of Family Health Internal, The Francois-Xavier Bagnoud Center for Public Health and Human Rights of the Harvard School of Public Health, UNAIDS. The Status and Trends of the Global HIV/AIDS Pandemic, 1996.
9. Raviglione MC, Narain JP, Kochi A. HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment. Bull World Health Organ 1992;70(4):515-26.
10. Centers for Disease Control (CDC). Transmission of multidrug-resistant tuberculosis from an HIV-positive client in a residential substance-abuse treatment facility-Michigan. MMWR Morb Mortal Wkly Rep 1991;40(8):129-31.
11. Centers for Disease Control (CDC). Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons: Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep 1991;40(34):585-91.
12. Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR Jr, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992;326(4):231-5.
13. Edlin BR, Tokars JI, Grieco MH, Crawford JT, Williams J, Sordillo EM, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;326(23):1514-21.
14. Murcia-Aranguren MI, Gómez-Marin JE, Alvarado FS, Bustillo JG, de Mendivelson E, Gómez B, et al. Frequency of tuberculous and non-tuberculous mycobacteria in HIV infected patients from Bogota, Colombia. BMC Infect Dis 2001;1:21.
15. Horsburgh CR Jr. Epidemiology of mycobacterial diseases in AIDS. Res Microbiol 1992;143(4):372-7.
16. Bloch AB, Cauthen GM, Onorato IM, Dansbury KG, Kelly GD, Driver CR, et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994;271(9):665-71.
17. O'Brien RJ. Drug-resistant tuberculosis: etiology, management and prevention. Semin Respir Infect 1994;9(2):104-12.
18. Montoya JC, Santiago E, Manalo M, Dy E. Clinical, radiologic and microbiologic features of mycobacterial infection in patients with HIV. Phil J Microbiol Infect Dis 1998;27(3):97-101.
19. th International Conference on AIDS. Stockholm, 1998.
20. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000;49(RR-6):1-51.
21. Lein AD, von Reyn CF, Ravn P, Horsburgh CR Jr, Alexander LN, Andersen P. Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis. Clin Diagn Lab Immunol 1999;6(4):606-9.
22. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000;356(9235):1099-104.
23. Rolinck-Werninghaus C, Magdorf K, Stark K, Lyashchenko K, Gennaro ML, Colangeli R, et al. The potential of recombinant antigens ESAT-6, MPT63 and mig for specific discrimination of Mycobacterium tuberculosis and M. avium infection. Eur J Pediatr 2003;162(7-8):534-6.
24. Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004;350(20):2060-7.
25. Converse PJ, Jones SJ, Astemborski J, Vlahov D, Graham NMH. Comparison of a tuberculin Interferon-γ assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection. J Infectious Dis 1997;176:144-50.